Drugs / TR-01-IR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05727189 | Feb 2023 → Dec 2027 expected | — | Terran Biosciences Australia Pty Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TR-01-IR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05727189 ↗ |
| Route | Oral | “single p.o. dose escalation (3 dose levels) of 4 forms investigational study drug and placebo” NCT05727189 ↗ |